Measuring #cellavidity enabled scientists to identify robust #CAR#NKs that efficiently kill solid tumors. Enhanced avidity in CAR-NK therapies using a molecular anchor helps fine-tune synaptic interactions. Learn how avidity can transform CAR-NK design buff.ly/3OnoeTS
π Dive into groundbreaking insights with Prof. Marcela Maus! π Watch our most-watched webinar on novel CAR-T developments and avidity. π
π Check out the highlighted webinar here: buff.ly/3tGPwxk
#CellAvidity #CAR -T #Immunotherapy #Webinar π
From 5 to 8 December we will be at #BSI22 in Liverpool! Swing by booth #34 to learn all about #cellavidity and how measuring this crucial #biomarker can accelerate your cutting-edge #research in #celltherapy .
Join our upcoming #IOdigest webinar, where Dr. Julian Ashby will dive deep into #NK cell biology and #therapies and showcase how #cellavidity is crucial in predicting #NK , #CARNK , #gammadeltaTcells , and #macrophage therapeutic efficacy.
Register now!β‘οΈbit.ly/3V6zWnj
Weren't able to join? A recording of our Technology Seminar with LUMICKS is now available on YouTube: youtu.be/xLGnSBUcpew. Subscribe to the channel for the latest educational content. #bioinformatics #genomics #cellavidity
Deep dive into #NaturalKillerCell biology and #therapies , and discover how #cellavidity is a key indicator of therapeutic efficacy for innate immune cells. Join our upcoming #IOdigest webinar to learn more! β‘οΈbit.ly/3Vja4oh
π Dive into groundbreaking insights with Prof. Marcela Maus! π Watch our most-watched webinar on novel CAR-T developments and avidity. π
π Check out the highlighted webinar here: bit.ly/3RPrN66
#CellAvidity #CAR -T #Immunotherapy #Webinar π
Measuring #cellavidity enabled scientists to identify robust #CAR#NKs that efficiently kill solid tumors. Enhanced avidity in CAR-NK therapies using a molecular anchor helps fine-tune synaptic interactions. Learn how avidity can transform CAR-NK design bit.ly/3SGXCif
A beautiful example of the role of #cellavidity in T-cell biology!
#cellavidity #Immunotherapy #tcells
I was asked about #cellavidity , sonI answered.
Lymphocyte Engineering LUMICKS
youtu.be/iV0_6ZAWW7E
Limited efficacy of APRIL CAR in patients with multiple myeloma indicate challenges in the use of natural ligands for CAR T-cell therapy #CellAvidity #CART #Immunotherapy jitc.bmj.com/content/11/6/eβ¦
Wonderful work from Dr Marcela Maus lab Harvard Medical School on how #cellavidity measurements help optimizing CAR-T design for AML! Wonderful to see the LUMICKS z-Movi being used in the field!